Maiko Sekiguchi
Tokyo University of Agriculture and Technology
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Maiko Sekiguchi.
Journal of Immunology | 2001
Maiko Sekiguchi; Yuko Futei; Yoshiko Fujii; Toshiro Iwasaki; Takeji Nishikawa; Masayuki Amagai
Desmoglein (Dsg) is a cadherin-type adhesion molecule found in desmosomes. Dsg1 and Dsg3 are the target Ags in the autoimmune blistering diseases pemphigus foliaceus (PF) and pemphigus vulgaris (PV), respectively. To map conformational epitopes of Dsg1 and Dsg3 in PF and PV, we generated Dsg1- and Dsg3-domain-swapped molecules and point-mutated Dsg3 molecules with Dsg1-specific residues by baculovirus expression. The swapped domains were portions of the N-terminal extracellular domains of Dsg1 (1–496) and Dsg3 (1–566), which have similar structures but distinct epitopes. The binding of autoantibodies to the mutant molecules was assessed by competition ELISAs. Domain-swapped molecules containing the N-terminal 161 residues of Dsg1 and Dsg3 yielded >50% competition in 30/43 (69.8%) PF sera and 31/40 (77.5%) PV sera, respectively. Furthermore, removal of Abs against the 161 N-terminal residues of Dsg1 by immunoadsorption eliminated the ability of PF sera to induce cutaneous blisters in neonatal mice. Within these N-terminal regions, most of the epitopes were mapped to residues 26–87 of Dsg1 and 25–88 of Dsg3. Furthermore, a point-mutated Dsg3 molecule containing Dsg1-specific amino acid substitutions (His25, Cys28, Ala29) reacted with anti-Dsg1 IgG, thus defining one of the epitopes of Dsg1. Using the predicted three-dimensional structure of classic cadherins as a model, these findings suggest that the dominant autoimmune epitopes in both PF and PV are found in the N-terminal adhesive surfaces of Dsgs.
Veterinary Dermatology | 2011
Keita Iyori; Keiko Futagawa-Saito; Junzo Hisatsune; Masahiko Yamamoto; Maiko Sekiguchi; Kaori Ide; Won-Geun Son; Thierry Olivry; Motoyuki Sugai; Tsuguaki Fukuyasu; Toshiroh Iwasaki; Koji Nishifuji
Staphylococcal exfoliative toxins are known to digest desmoglein (Dsg) 1, a desmosomal cell-cell adhesion molecule, thus causing intraepidermal splitting in human bullous impetigo, staphylococcal scalded skin syndrome and swine exudative epidermitis. Recently, a novel exfoliative toxin gene (exi), whose sequence shares significant homology with previously identified exfoliative toxins, was isolated from Staphylococcus pseudintermedius. Little is known about the pathogenic involvement of this toxin in canine pustular diseases such as impetigo. The aim of this study was to determine whether EXI, the product of the exi gene, digests canine Dsg1 and causes intraepidermal splitting in canine skin. An exi gene was isolated from chromosomal DNA of an S. pseudintermedius strain obtained from a pustule of a dog with impetigo, and was used to produce a recombinant EXI by Escherichia coli expression. When purified recombinant EXI was injected intradermally into normal dogs, it caused the development of vesicles or erosions with superficial epidermal splitting. In addition, the EXI abolished immunofluorescence for Dsg1, but not for Dsg3, at the injection sites. Moreover, the EXI directly degraded baculovirus-secreted recombinant extracellular domains of canine Dsg1, but not that of canine Dsg3, in vitro. The EXI also degraded mouse Dsg1α and swine Dsg1, but not human Dsg1, mouse Dsg1β and Dsg1γ. Conversely, recombinant SIET, previously designated as S. intermedius exfoliative toxin, did not cause intraepidermal splitting or degradation of any Dsgs. These findings indicate that EXI has a proteolytic activity that digests canine Dsg1, and this characteristic might be involved in the pathogenesis of intraepidermal splitting in canine impetigo.
The Japanese Journal of Veterinary Dermatology | 2012
Kentaro Yamagishi; Maiko Sekiguchi
15週齢の雌のトイ・プードルにおいて,眼瞼および口吻の腫脹とびらんを中心とした皮膚病変と,混合ワクチン接種部位における限局性の腫脹と自壊が認められた。病理組織学的検査により,顔面は重度の毛包炎を特徴とする無菌性化膿性肉芽腫性皮膚炎が,自壊したワクチン接種部位は無菌性肉芽腫性脂肪織炎が認められた。検査結果および臨床経過から若年性無菌性肉芽腫性皮膚炎および無菌性脂肪織炎と診断した。両病変とも免疫抑制用量のプレドニゾロンによる治療が奏功した。
Journal of Investigative Dermatology | 2000
Yuko Futei; Masayuki Amagai; Maiko Sekiguchi; Koji Nishifuji; Yoshiko Fujii; Takeji Nishikawa
Journal of Veterinary Medical Science | 2009
Hiromi Harada; Yasuyuki Endo; Maiko Sekiguchi; Asuka Setoguchi; Yasuyuki Momoi
Journal of Veterinary Medical Science | 2009
Atsushi Yabuzoe; Shinichi Yokoi; Maiko Sekiguchi; Yasuyuki Momoi; Kaori Ide; Koji Nishifuji; Toshiroh Iwasaki
Australian Veterinary Journal | 2002
Kadoya-Minegishi M; Seong-Jun Park; Maiko Sekiguchi; Koji Nishifuji; Yasuyuki Momoi; Toshiroh Iwasaki
Journal of Equine Science | 2001
Hiroto Yamasaki; Motoaki Goto; Toyohiko Yoshihara; Maiko Sekiguchi; Katsuhiko Konno; Yasuyuki Momoi; Toshiroh Iwasaki
Journal of Veterinary Medical Science | 2010
Sumiyo Endo; Maiko Sekiguchi; Yuji Kishimoto; Rui Kano; Sinobu Aoki; Tamiko Sichinohe; Atsuhiko Hasegawa
Journal of Veterinary Medicine Series A-physiology Pathology Clinical Medicine | 2005
Koji Nishifuji; Y. Ueda; A. Sano; Michiyo Kadoya; K. Kamei; Maiko Sekiguchi; K. Nishimura; Toshiroh Iwasaki